Description

OBJECTIVE

O Webinar ABCDI tem como objetivo destacar a relevância dos laudos evolutivos como ferramenta essencial na prática clínica dos mastologistas. A proposta é apresentar como esses documentos contribuem para:

Acompanhamento preciso da evolução clínica das pacientes, permitindo decisões mais seguras e embasadas.
Integração multidisciplinar, facilitando a comunicação entre mastologistas, oncologistas, radiologistas e demais profissionais de saúde.
Padronização das informações médicas, garantindo maior clareza nos registros e evitando interpretações divergentes.
Aprimoramento da qualidade assistencial, com foco na personalização do tratamento e no monitoramento contínuo dos resultados.

Ao final, os participantes compreenderão como os laudos evolutivos fortalecem a prática mastológica, promovendo mais eficiência, precisão diagnóstica e segurança para as pacientes.

MODERATORS

Dr. Juliana Tapajós
2nd Vice President of the CBR (2025/2026), Director of Professional Defense of the CBR (2023/2024 and 2021/2022), Counselor of the CRM- AM 2023-2028, Former Vice President Northern Region- CBR, Former President SORAM, Medical Coordinator of the Samel Group and Radiology of the Delphina Aziz Hospital and Medical Specialist in RDDI.

Dr. Ricardo Rocha
Director of ABCDI (2025/2026), Doctor graduated from the federal university of Ceará in 1997, Medical residency in radiology and diagnostic imaging at the Mandaqui hospital complex - São Paulo SP, Postgraduate studies in head and neck radiology and neuroradiology at IES/FAMETRO, Former vice-president and director of professional defense at SOCEARA, Director of SINDESSEC and Coordinator of the imaging department of the association of hospitals in Ceará.

Carlos Moura
He is a Business Administrator with an MBA in IT from USP and an International Human Talent Development Course from the University of Central Florida. With extensive knowledge of the Brazilian diagnostic medicine market, he is an Economic Advisor to the Brazilian College of Radiology and Diagnostic Imaging (CBR), which he represents as a member of the Supplementary Health Information Standardization Committee (COPISS) and the Sector Quality Assessment Technical Committee (COTAQ). He is a partner in Moura Assessoria, a management consultancy in the field of diagnostic medicine. Over the last fifteen years, he has held executive positions in the administrative, commercial and financial areas in the diagnostic medicine segment, among others.